Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria ...

European Commission approves Sanofi & Regeneron’s Dupixent to treat young children with chronic spontaneous urticaria: Paris Wednesday, April 15, 2026, 09:00 Hrs [IST] The Europ ...

Children who were enrolled for more than 40 hours per week had the highest rates of developmental vulnerabilities, major government research tracking 274,000 Australian children has found.

Dog-assisted care during early dental visits may reduce anxiety in children with autism spectrum disorder, with benefits ...

The study is part of the ICMR’s National Health Research Priority Projects. It will run in one district each in Karnataka, ...

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduce ...

Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can already provide sufficient statistical power to support ...

European registry data reveal paediatric autoimmune liver disease has high survival but limited control. Read more.

In A Nutshell The findings are from an animal study and cannot be directly applied to humans, but the biological pathways ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) William McCorkle, College of Charleston (THE CONVERSATION) All immigrants, regardless ...

A landmark U.S. study published on April 13, 2025 in the Proceedings of the National Academy of Sciences found no connection ...